D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 157 SEK -0.51% Market Closed
Market Cap: 2.6B SEK

Wall Street
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 184.62 SEK with a low forecast of 173.72 SEK and a high forecast of 199.5 SEK.

Lowest
Price Target
173.72 SEK
11% Upside
Average
Price Target
184.62 SEK
18% Upside
Highest
Price Target
199.5 SEK
27% Upside
Devyser Diagnostics AB Competitors:
Price Targets
NBIX
Neurocrine Biosciences Inc
16% Upside
FENC
Fennec Pharmaceuticals Inc
62% Upside
RXRX
Recursion Pharmaceuticals Inc
34% Upside
SYRE
Spyre Therapeutics Inc
272% Upside
2142
Hbm Holdings Ltd
11% Downside
INSM
Insmed Inc
8% Upside
RNA
Avidity Biosciences Inc
70% Upside
ONCO
Oncopeptides AB
49% Upside

Revenue
Forecast

Revenue Estimate
Devyser Diagnostics AB

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 3 years is 32%.

28%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

Net Income
Forecast

Net Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVYSR's stock price target?
Price Target
184.62 SEK

According to Wall Street analysts, the average 1-year price target for DVYSR is 184.62 SEK with a low forecast of 173.72 SEK and a high forecast of 199.5 SEK.

What is Devyser Diagnostics AB's Revenue forecast?
Projected CAGR
32%

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 3 years is 32%.

Back to Top